BR0316512A - Composições nutricionais - Google Patents

Composições nutricionais

Info

Publication number
BR0316512A
BR0316512A BR0316512-4A BR0316512A BR0316512A BR 0316512 A BR0316512 A BR 0316512A BR 0316512 A BR0316512 A BR 0316512A BR 0316512 A BR0316512 A BR 0316512A
Authority
BR
Brazil
Prior art keywords
nutritional compositions
whey protein
palatinose
macrophages
interleukin
Prior art date
Application number
BR0316512-4A
Other languages
English (en)
Inventor
Hisae Kume
Makoto Yamaguchi
Kenji Mizumoto
Hajime Sasaki
Original Assignee
Meiji Dairies Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Dairies Corp filed Critical Meiji Dairies Corp
Publication of BR0316512A publication Critical patent/BR0316512A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C19/00—Cheese; Cheese preparations; Making thereof
    • A23C19/06—Treating cheese curd after whey separation; Products obtained thereby
    • A23C19/068—Particular types of cheese
    • A23C19/076—Soft unripened cheese, e.g. cottage or cream cheese
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C21/00—Whey; Whey preparations
    • A23C21/02—Whey; Whey preparations containing, or treated with, microorganisms or enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/30—Artificial sweetening agents
    • A23L27/33—Artificial sweetening agents containing sugars or derivatives
    • A23L27/34—Sugar alcohols
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/231—Pectin; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A23L29/35—Degradation products of starch, e.g. hydrolysates, dextrins; Enzymatically modified starches
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Zoology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dispersion Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Pediatric Medicine (AREA)
  • Microbiology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)

Abstract

"COMPOSIçõES NUTRICIONAIS". A presente invenção refere-se ao início de hepatopatia de galactosamina que é suprimido por composições nutricionais compreendendo como ingredientes essenciais: hidrolisados de proteína de soro de leite; lecitina e óleos e gorduras elevadas em ácido oléico, os quais são capazes de melhorar o metabolismo de lipídio; e palatinose tendo um efeito poupador de insulina. Além disso, o hidrolisado de proteína de soro de leite incluído nas composições nutricionais foi descoberto suprimir TNF-a induzido por endotoxina e produção de interleucina 6 (IL-6) em macrófagos.
BR0316512-4A 2002-11-22 2003-11-21 Composições nutricionais BR0316512A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002339948 2002-11-22
PCT/JP2003/014918 WO2004047566A1 (en) 2002-11-22 2003-11-21 Nutritional compositions

Publications (1)

Publication Number Publication Date
BR0316512A true BR0316512A (pt) 2005-10-04

Family

ID=32375794

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0316512-4A BR0316512A (pt) 2002-11-22 2003-11-21 Composições nutricionais

Country Status (17)

Country Link
US (2) US7563458B2 (pt)
EP (1) EP1575379B1 (pt)
JP (3) JP2006515287A (pt)
KR (1) KR101038354B1 (pt)
CN (1) CN100393243C (pt)
AR (1) AR042107A1 (pt)
AT (1) ATE468762T1 (pt)
BR (1) BR0316512A (pt)
CA (1) CA2506603C (pt)
DE (1) DE60332760D1 (pt)
DK (1) DK1575379T3 (pt)
ES (1) ES2344640T3 (pt)
HK (1) HK1083174A1 (pt)
MY (1) MY169519A (pt)
NZ (1) NZ540775A (pt)
TW (1) TWI317636B (pt)
WO (1) WO2004047566A1 (pt)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4947636B2 (ja) 2004-03-31 2012-06-06 カルピス株式会社 肝障害予防又は抑制剤
US20110274755A1 (en) * 2004-04-22 2011-11-10 Smith Howard J Supportive treatment of liver disease
US20100222259A1 (en) * 2004-07-09 2010-09-02 Hidekazu Arai Compositions for enhancing the production of PPAR and/or PPAR-associated factors
BRPI0610945B1 (pt) * 2005-05-31 2016-09-20 Arla Foods Amba Processo para a preparação de uma fonte de fosfatidilserina derivada de leite bovino, fonte e composição nutracêutica compreendendo a mesma”
KR101375933B1 (ko) * 2005-06-24 2014-03-18 카오카부시키가이샤 야채즙 및/또는 과즙 함유 용기 담긴 음료
DE102006017611A1 (de) * 2006-04-12 2007-10-25 Südzucker AG Mannheim/Ochsenfurt Kohlenhyrathaltige Sportgetränke
EP2010013B8 (en) * 2006-04-21 2009-09-09 Unilever N.V. Oxidation-stable granulate containing unsaturated fatty acids
US9662368B2 (en) * 2006-06-15 2017-05-30 Murray Goulburn Co-Operative., Limited Formulation comprising whey protein and hydrolysates for improving muscle recovery
DE102007009029A1 (de) * 2007-02-23 2008-09-04 Südzucker AG Mannheim/Ochsenfurt Niedrig-glykämische Mischungen
US9420807B2 (en) 2007-04-02 2016-08-23 Purina Animal Nutrition Llc Method of feeding young monogastric mammals and composition fed to young monogastric mammals
NZ555163A (en) * 2007-05-14 2010-05-28 Fonterra Co Operative Group Methods of immune or hematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer, cancer symptoms, or the symptoms of cancer treatments
WO2009023903A1 (en) * 2007-08-17 2009-02-26 Murray Goulburn Co-Operative Co. Limited Compositions comprising phospholipids
JP4941666B2 (ja) * 2007-10-19 2012-05-30 松谷化学工業株式会社 食物繊維強化剤及び食品
US8361534B2 (en) * 2007-12-20 2013-01-29 Abbott Laboratories Stable nutritional powder
WO2009085388A2 (en) * 2007-12-20 2009-07-09 Abbott Laboratories Stable nutritional powder
FI122252B (fi) * 2008-01-04 2011-10-31 Valio Oy Koostumus maksa-aineenvaihdunnan parantamiseksi ja diagnostinen menetelmä
US20110130637A1 (en) * 2008-03-20 2011-06-02 University Of Dundee Protein product for modifying cardiovascular health
DE102008032828A1 (de) * 2008-07-02 2010-01-07 Technische Universität Dresden Tryptophanhaltige Peptide aus alpha-Lactalbumin mit blutdrucksenkender und vasoprotektiver Wirkung für biofunktionelle Lebensmittel
CN102264380A (zh) * 2009-01-19 2011-11-30 营养株式会社 低浓度的营养组合物
WO2010097484A2 (es) * 2009-02-25 2010-09-02 Productos Carnicos Elaborados Con Aceite De Oliva Virgen, S.L. Composición alimentaria
DK2413720T3 (da) 2009-04-02 2019-09-30 Novozymes As Fremgangsmåde til fremstilling af et mælkebaseret proteinhydrolysat
JP5946642B2 (ja) * 2009-11-30 2016-07-06 株式会社明治 小腸に良い栄養組成物
EP2332428B1 (en) * 2009-12-04 2014-08-20 MJN U.S. Holdings LLC Nutritional Formulation comprising a cow's milk peptide-containing hydrolysate and/or peptides derived thereof for tolerance induction
JP5779348B2 (ja) * 2010-12-27 2015-09-16 日油株式会社 酸性液状栄養組成物
US9532586B2 (en) 2011-01-06 2017-01-03 Holista Biotech Sdn. Bhd. Reduced sodium composition
US9352495B1 (en) * 2011-03-14 2016-05-31 HSP Holdings, LLC Barrier release agent
FR2976399B1 (fr) 2011-06-09 2013-05-31 Veolia Proprete Procede de deconstruction au moins partielle d'un ecran plat de visualisation
WO2013080911A1 (ja) * 2011-11-30 2013-06-06 株式会社明治 腸内菌叢改善用栄養組成物
TWI472519B (zh) * 2011-12-20 2015-02-11 Nat Univ Dong Hwa 含正－亞丁基苯酞之醫藥組成物用於治療肝損傷及改善肝功能
US8927601B2 (en) 2011-12-20 2015-01-06 National Dong Hwa University Uses of N-butylidenephthalide in treating a liver injury and improving liver function
EP2674159B1 (de) * 2012-06-15 2016-04-27 Phrontier S.A.R.L. Pharmazeutische Zusammensetzung für die Leber-Regeneration
JP6277957B2 (ja) * 2012-08-20 2018-02-14 味の素株式会社 栄養組成物
US9138455B2 (en) 2013-03-15 2015-09-22 Mead Johnson Nutrition Company Activating adiponectin by casein hydrolysate
US9352020B2 (en) 2013-03-15 2016-05-31 Mead Johnson Nutrition Company Reducing proinflammatory response
US9345727B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component and uses thereof
US9289461B2 (en) 2013-03-15 2016-03-22 Mead Johnson Nutrition Company Reducing the risk of autoimmune disease
US9345741B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof
US8889633B2 (en) 2013-03-15 2014-11-18 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof
JP2016531114A (ja) * 2013-07-31 2016-10-06 株式会社明治 腫瘍の成長を阻止する栄養組成物
DE102013018267A1 (de) * 2013-10-31 2015-04-30 Jan Berg Quarkhaltige Zusammensetzung
ES2544153B1 (es) 2014-02-24 2016-06-06 Ntd Labs, S.L. Uso de un hidrolizado de caseína como agente antiviral
CN104082656B (zh) * 2014-06-12 2017-04-12 广东省农业科学院蚕业与农产品加工研究所 一种适合肝病病人的营养膳及其制作方法
CN104187624B (zh) * 2014-08-07 2016-06-08 逯明福 综合营养粉及其制备方法
ES2885851T3 (es) 2014-09-30 2021-12-15 Nestle Sa Composición nutricional para la utilización en la estimulación de la maduración del hígado
CN107404922B (zh) * 2015-03-30 2021-09-14 雀巢产品有限公司 乳基蛋白质水解物及由其制备的组合物
WO2016174651A2 (en) * 2015-10-01 2016-11-03 Frieslandcampina Nederland B.V. Liquid nutritional composition comprising micellar casein and hydrolysed whey protein
CN105520019A (zh) * 2015-11-25 2016-04-27 广西巴马活益生生物科技有限公司 一种多菌种微生物复合功能型饮料制剂及其制备方法
CN108430490A (zh) * 2015-12-03 2018-08-21 株式会社明治 营养组合物
WO2017126645A1 (ja) 2016-01-22 2017-07-27 株式会社明治 エンドトキシンの血中移行阻害用組成物
JP6842244B2 (ja) * 2016-05-10 2021-03-17 花王株式会社 アイスクリーム類
JP6325036B2 (ja) * 2016-08-19 2018-05-16 株式会社明治 抗がん剤に起因する末梢神経障害を改善するための組成物
KR101837299B1 (ko) 2016-10-21 2018-03-09 김나연 발효 유청단백질의 제조방법 및 발효 유청단백질
US11197917B2 (en) * 2017-12-01 2021-12-14 ByHeart, Inc. Formulations for nutritional support in subjects in need thereof
JP7195746B2 (ja) * 2018-03-20 2022-12-26 株式会社明治 炎症性貧血処置のための組成物
CN108707327A (zh) * 2018-06-14 2018-10-26 湖北文理学院 复合材料及其制备方法
CN110663960A (zh) * 2019-08-23 2020-01-10 北京康爱营养医学研究院 一种营养组合物及其制备方法、应用
KR20220122264A (ko) 2021-02-26 2022-09-02 (주)서울에프엔비 항산화 및 항노화 기능성이 우수한 우유단백질 가수분해물의 제조방법과 이를 이용하여 제조한 기능성 발효유 식품
CN114271480B (zh) * 2021-12-31 2023-10-20 烟台大学 一种高稳定性终末期阶段肾病全营养食品乳剂及其制备工艺
KR20230165449A (ko) 2022-05-27 2023-12-05 (주)서울에프엔비 피부 노화 예방 기능성 요구르트의 제조방법 및 이를 이용하여 제조한 요구르트 제품

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4600588A (en) 1980-08-20 1986-07-15 Ernster John H Milk protein hydrolysate and process of preparation
JPS58126767A (ja) * 1982-01-22 1983-07-28 Ajinomoto Co Inc 肝臓病患者用栄養組成物
WO1988008259A1 (en) * 1987-05-01 1988-11-03 Otsuka Pharmaceutical Co., Ltd. Nutritive emulsion preparation
EP0421309B2 (en) 1989-10-02 2001-08-16 Novartis Nutrition AG Protein hydrolysates
JPH03167723A (ja) 1989-11-27 1991-07-19 Matsushita Electric Works Ltd サーモスイッチ
US5198250A (en) * 1990-07-16 1993-03-30 Lipotech Partners Limited Partnership Food and pharmaceutical compositions containing short chain monounsaturated fatty acids and methods of using
ES2033193B1 (es) 1990-10-30 1994-01-16 Ganadera Union Ind Agro Mezcla grasa para nutricion infantil y de adultos.
DE69216231T2 (de) 1991-05-31 1997-06-12 Danmark Protein As Verfahren zur herstellung eines molkeprotein-hydrolysates
JPH0515339A (ja) * 1991-07-10 1993-01-26 Terumo Corp タンパク質様組成物および高度侵襲用栄養剤ならびに肝疾患用栄養剤
US5405637A (en) * 1993-06-30 1995-04-11 Bristol-Myers Squibb Company Milk protein partial hydrolysate and infant formula containing same
US5714472A (en) * 1993-12-23 1998-02-03 Nestec Ltd. Enternal formulation designed for optimized nutrient absorption and wound healing
JP3396090B2 (ja) * 1994-08-18 2003-04-14 日東薬品工業株式会社 粉末栄養組成物
US5993221A (en) 1997-05-01 1999-11-30 Beth Israel Deaconess Medical Center, Inc. Dietary formulation comprising arachidonic acid and methods of use
MY129566A (en) * 1999-01-19 2007-04-30 Nestle Sa A hypoallergenic composition containing tolerogenic peptides inducing oral tolerance
EP1034704A1 (en) * 1999-03-12 2000-09-13 Societe Des Produits Nestle S.A. Nutritional composition intended for specific gastro-intestinal maturation in premature mammals
US6998259B1 (en) * 1999-05-20 2006-02-14 Davisco Foods International Enzymatic treatment of whey proteins for the production of antihypertensive peptides and the resulting products
JP2001233783A (ja) * 2000-02-21 2001-08-28 Terumo Corp 術前栄養剤
JP2001247474A (ja) * 2000-03-07 2001-09-11 Snow Brand Milk Prod Co Ltd 肝疾患予防及び／又は治療剤
NZ506866A (en) * 2000-09-11 2003-05-30 New Zealand Dairy Board Bioactive whey protein hydrolysate free of bitter flavours wherein the enzyme used is a heat labile protease
JP2002226394A (ja) * 2001-02-01 2002-08-14 Meiji Milk Prod Co Ltd 脂質代謝改善組成物
JP2002255824A (ja) * 2001-02-27 2002-09-11 Meiji Milk Prod Co Ltd 免疫賦活組成物
MY135783A (en) 2001-09-07 2008-06-30 Meiji Dairies Corp Nutritional composition for controlling blood sugar level
US6830766B2 (en) * 2002-03-08 2004-12-14 Mccabe David J. High protein foodstuff
JP4278028B2 (ja) * 2002-12-18 2009-06-10 明治乳業株式会社 炎症性サイトカイン産生抑制活性を有するペプチド
JP5015339B2 (ja) 2011-06-02 2012-08-29 株式会社日本マイクロニクス 液晶パネル点灯検査装置

Also Published As

Publication number Publication date
KR20050083950A (ko) 2005-08-26
JP5688818B2 (ja) 2015-03-25
DE60332760D1 (de) 2010-07-08
AR042107A1 (es) 2005-06-08
CA2506603C (en) 2011-06-28
US20060073186A1 (en) 2006-04-06
JP2013136602A (ja) 2013-07-11
CN100393243C (zh) 2008-06-11
CN1741749A (zh) 2006-03-01
US8778404B2 (en) 2014-07-15
US7563458B2 (en) 2009-07-21
ATE468762T1 (de) 2010-06-15
NZ540775A (en) 2007-08-31
JP2011006425A (ja) 2011-01-13
CA2506603A1 (en) 2004-06-10
JP2006515287A (ja) 2006-05-25
ES2344640T3 (es) 2010-09-02
MY169519A (en) 2019-04-22
TW200412990A (en) 2004-08-01
EP1575379A1 (en) 2005-09-21
HK1083174A1 (en) 2006-06-30
DK1575379T3 (da) 2010-09-13
US20090233865A1 (en) 2009-09-17
AU2003283831A1 (en) 2004-06-18
EP1575379B1 (en) 2010-05-26
WO2004047566A1 (en) 2004-06-10
TWI317636B (en) 2009-12-01
KR101038354B1 (ko) 2011-06-01

Similar Documents

Publication Publication Date Title
BR0316512A (pt) Composições nutricionais
DK1419768T3 (da) Præparater med virkning til forebyggelse eller bedring af tilstande eller sygdomme forårsaget af hjernehypofunktion
Mitre et al. Oral intake of shark liver oil modifies lipid composition and improves motility and velocity of boar sperm
BR0308799A (pt) co-glóbulos de dha e alecrim e método de uso
WO2002080860A3 (en) Methods, compounds, and compositions for reducing body fat and modulating fatty acid metabolism
UY29195A1 (es) Procesos para la preparacion de composiciones oleosas
NO20004615D0 (no) FremgangsmÕte for fremstilling av linolsyre, og preparater inneholdende denne
TW200744463A (en) Nutritional supplement containing long-chain polyunsaturated fatty acids
ATE394365T1 (de) Verfahren zur synthese von verbindungen vom ceramidtyp
BR0112073A (pt) Combinações terapêuticas de ácidos graxos
EA201000400A1 (ru) Твердые жировые композиции, содержащие полиненасыщенные жирные кислоты, и способы их получения и использования
EA200970238A1 (ru) ПРИМЕНЕНИЕ МАСЕЛ С DPA(n-6) В ДЕТСКОМ ПИТАНИИ
ES2196983B1 (es) Polvo nutriente para una formula infantil con aminoacidos libres y nucleotidos.
CR6310A (es) 1,2,3,4-tetrahidroquinolinas 2-sustituidas 4-carboxiamino sustituidas
DE602005010876D1 (de) Neuartige biaromatische ppar-rezeptoren aktivierende zusammensetzungen und ihre verwendung in kosmetischen oder pharmazeutischen zusammensetzungen
WO2005046580A3 (en) Dietary and other compositions, compounds, and methods for reducing body fat, controlling appetite, and modulating fatty acid metabolism
BR0308713A (pt) Co-esférula de dha e alecrim, e métodos de uso
HK1081078A1 (en) Compositions comprising protein and fatty acid and processes of their preparation
BR9909234A (pt) Método para fornecimento de glutamina
ATE422160T1 (de) Physiologisch aktive zusammensetzung auf phosphatidylserin-basis
BR0312097A (pt) Corpo graxo vegetal, utilização de um corpo graxo, produto alimentìcio e processo de preparação de um produto alimentìcio
ATE357934T1 (de) Pharmazeutische zusammensetzung zur verhinderung der entwicklung und progression von mykotischen hautoberflächenerkrankungen
ATE453614T1 (de) Sphingolipiden
Itoi et al. Changes in mitochondrial fatty acid composition following temperature acclimation of carp and their possible effects on F o F 1-ATPase activity
NO996074D0 (no) Voksestere anriket i <omega>-3 umettede fettsyrer, deres fremstilling og deres anvendelse

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25D Requested change of name of applicant approved

Owner name: MEIJI CO., LTD. (JP)

Free format text: NOME ALTERADO DE: MEIJI DAIRIES CORPORATION

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B11D Dismissal acc. art. 38, par 2 of ipl - failure to pay fee after grant in time
B15K Others concerning applications: alteration of classification

Ipc: A61K 45/06 (2006.01), A23C 19/076 (2006.01), A23C